The local corticotropin-releasing hormone receptor 2 signalling pathway partly mediates hypoxia-induced increases in lipolysis via the cAMP-protein kinase A signalling pathway in white adipose tissue

Molecular and Cellular Endocrinology

Volumn 392, Issue 1-2, 2014, Pages 106-114

  Xiong, Yanlei ^a   Qu, Zhuan ^b   Chen, Nan ^a   Gong, Hui ^a   Song, Mintao ^a   Chen, Xuequn ^b   Du, Jizeng ^b   Xu, Chengli ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Corticotropin releasing hormone receptor 2; Hypoxia; Lipolysis; White adipose tissue

Indexed keywords

ACYL COENZYME A DESATURASE; ASTRESSIN; CHOLESTEROL; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HORMONE SENSITIVE LIPASE; OXYGEN; PERILIPIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; ASTRESSIN-2B; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLOPEPTIDE; FATTY ACID; PEPTIDE FRAGMENT;

ADULT; ALTITUDE; ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FOOD INTAKE; HYPOBARISM; HYPOXIA; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MALE; NONHUMAN; OXYGEN TENSION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE; ADIPOCYTE; ANIMAL; ANOXIA; CELL SIZE; DRUG EFFECTS; ENZYMOLOGY; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OBESITY; OXIDATION REDUCTION REACTION; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ADIPOSITY; ALTITUDE; ANIMALS; ANOXIA; BODY WEIGHT; CELL SIZE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FATTY ACIDS; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; LIPOGENESIS; LIPOLYSIS; MALE; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84901807985     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.05.012     Document Type: Article

References (48)

1. Armellini, F., Zamboni, M., Robbi, R., Todesco, T., Bissoli, L., et al. 1997. The effects of high altitude trekking on body composition and resting metabolic rate. Hormone and metabolic research=Hormon- und Stoffwechselforschung = Hormones et metabolisme, 29, pp. 458-61.
2. Bakshi V.P., Newman S.M., Smith-Roe S., Jochman K.A., Kalin N.H. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala. J. Neurosci.: Off. J. Soc. Neurosci. 2007, 27:10568-10577.
3. Benso A., Broglio F., Aimaretti G., Lucatello B., Lanfranco F., et al. Endocrine and metabolic responses to extreme altitude and physical exercise in climbers. Eur. J. Endocrinol./Eur. Fed. Endocr. Soc. 2007, 157:733-740.
4. Boyer S.J., Blume F.D. Weight loss and changes in body composition at high altitude. J. Appl. Physiol. 1984, 57:1580-1585.
5. Brasaemle D.L. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 2007, 48:2547-2559.
6. Buhler K., Plaisance I., Dieterle T., Brink M. The human urocortin 2 gene is regulated by hypoxia: identification of a hypoxia-responsive element in the 3'-flanking region. Biochem. J. 2009, 424:119-127.
7. Chao H., Digruccio M., Chen P., Li C. Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue. Endocrinology 2012, 153:166-176.
8. Chen A., Brar B., Choi C.S., Rousso D., Vaughan J., et al. Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle. Proc. Nat. Acad. Sci. USA 2006, 103:16580-16585.
9. Chen P., Hover C.V., Lindberg D., Li C. Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus. Front. Endocrinol. 2012, 3:180.
10. Chen X.Q., Dong J., Niu C.Y., Fan J.M., Du J.Z. Effects of hypoxia on glucose, insulin, glucagon, and modulation by corticotropin-releasing factor receptor type 1 in the rat. Endocrinology 2007, 148:3271-3278.
11. Dautzenberg F.M., Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 2002, 23:71-77.
12. Evans R.M., Barish G.D., Wang Y.X. PPARs and the complex journey to obesity. Nat. Med. 2004, 10:355-361.
13. Famulla S., Schlich R., Sell H., Eckel J. Differentiation of human adipocytes at physiological oxygen levels results in increased adiponectin secretion and isoproterenol-stimulated lipolysis. Adipocyte 2012, 1:132-181.
14. Gentil C., Le Jan S., Philippe J., Leibowitch J., Sonigo P., et al. Is oxygen a key factor in the lipodystrophy phenotype?. Lipids Health Dis. 2006, 5:27.
15. Gerin I., Dolinsky V.W., Shackman J.G., Kennedy R.T., Chiang S.H., et al. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J. Biol. Chem. 2005, 280:23024-23031.
16. Grammatopoulos D.K. Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br. J. Pharmacol. 2012, 166:85-97.
17. Green A., Rumberger J.M., Stuart C.A., Ruhoff M.S. Stimulation of lipolysis by tumor necrosis factor-alpha in 3T3-L1 adipocytes is glucose dependent: implications for long-term regulation of lipolysis. Diabetes 2004, 53:74-81.
18. Hashimoto T., Yokokawa T., Endo Y., Iwanaka N., Higashida K., Taguchi S. Modest hypoxia significantly reduces triglyceride content and lipid droplet size in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2013, 440:43-49.
19. Imperatore A., Rolfo A., Petraglia F., Challis J.R., Caniggia I. Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3. Reprod. Sci. 2010, 17:833-843.
20. Jamieson P.M., Cleasby M.E., Kuperman Y., Morton N.M., Kelly P.A., et al. Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet. Diabetologia 2011, 54:2392-2403.
21. Kim K.H., Song M.J., Chung J., Park H., Kim J.B. Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem. Biophys. Res. Commun. 2005, 333:1178-1184.
22. Kozak L.P., Koza R.A., Anunciado-Koza R. Brown fat thermogenesis and body weight regulation in mice: relevance to humans. Int. J. Obes. (Lond) 2010, 34(Suppl 1.):S23-S27.
23. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Nat. Acad. Sci. USA 2001, 98:7570-7575.
24. Li J., Qi D., Cheng H., Hu X., Miller E.J., et al. Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart. Proc. Nat. Acad. Sci. USA 2013, 110:16133-16138.
25. Magnoni L., Vaillancourt E., Weber J.M. In vivo regulation of rainbow trout lipolysis by catecholamines. J. Exp. Biol. 2008, 211:2460-2466.
26. Miyoshi H., Souza S.C., Zhang H.H., Strissel K.J., Christoffolete M.A., et al. Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J. Biol. Chem. 2006, 281:15837-15844.
27. Ni Q., Shao Y., Wang Y.Z., Jing Y.H., Zhang Y.C. Impact of high altitude on the hepatic fatty acid oxidation and synthesis in rats. Biochem. Biophys. Res. Commun. 2014.
28. Nishiyama Y., Goda N., Kanai M., Niwa D., Osanai K., et al. HIF-1alpha induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice. J. Hepatol. 2012, 56:441-447.
29. Rassouli O., Liapakis G., Lazaridis I., Sakellaris G., Gkountelias K., et al. A novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblasts. PLoS One 2011, 6:e21654.
30. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., et al. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Nat. Acad. Sci. USA 2001, 98:2843-2848.
31. Rose M.S., Houston C.S., Fulco C.S., Coates G., Sutton J.R., Cymerman A. Operation everest. II: Nutrition and body composition. J. Appl. Physiol. 1988, 65:2545-2551.
32. Rosen E.D., Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444:847-853.
33. Seres J., Bornstein S.R., Seres P., Willenberg H.S., Schulte K.M., et al. Corticotropin-releasing hormone system in human adipose tissue. J. Clin. Endocrinol. Metab. 2004, 89:965-970.
34. Siersbaek R., Nielsen R., Mandrup S. Transcriptional networks and chromatin remodeling controlling adipogenesis. Trends Endocrinol. Metab.: TEM 2012, 23:56-64.
35. Solinas G., Summermatter S., Mainieri D., Gubler M., Montani J.P., et al. Corticotropin-releasing hormone directly stimulates thermogenesis in skeletal muscle possibly through substrate cycling between de novo lipogenesis and lipid oxidation. Endocrinology 2006, 147:31-38.
36. Sztalryd C., Xu G., Dorward H., Tansey J.T., Contreras J.A., et al. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation. J. Cell Biol. 2003, 161:1093-1103.
37. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 2008, 77:289-312.
38. Trayhurn P., Wang B., Wood I.S. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch. Physiol. Biochem. 2008, 114:267-276.
39. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004, 92:347-355.
40. Tsatsanis C., Dermitzaki E., Venihaki M., Chatzaki E., Minas V., et al. The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function. Cell. Mol. Life Sci.: CMLS 2007, 64:1638-1655.
41. van den Borst B., Schols A.M., de Theije C., Boots A.W., Kohler S.E., et al. Characterization of the inflammatory and metabolic profile of adipose tissue in a mouse model of chronic hypoxia. J. Appl. Physiol. (1985) 2013, 114:1619-1628.
42. Wang B., Wood I.S., Trayhurn P. Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J. Endocrinol. 2008, 198:127-134.
43. Weidemann A., Johnson R.S. Biology of HIF-1alpha. Cell Death Differ. 2008, 15:621-627.
44. White U.A., Stephens J.M. Transcriptional factors that promote formation of white adipose tissue. Mol. Cell. Endocrinol. 2010, 318:10-14.
45. Wiesner S., Haufe S., Engeli S., Mutschler H., Haas U., et al. Influences of normobaric hypoxia training on physical fitness and metabolic risk markers in overweight to obese subjects. Obesity (Silver Spring) 2010, 18:116-120.
46. Yakabi K., Noguchi M., Ohno S., Ro S., Onouchi T., et al. Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors. American journal of physiology. Endocrinol. Metab. 2011, 301:E72-E82.
47. Zhou S., Lechpammer S., Greenberger J.S., Glowacki J. Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling. J. Biol. Chem. 2005, 280:22688-22696.
48. Zmuda-Trzebiatowska E., Oknianska A., Manganiello V., Degerman E. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Cell. Signal. 2006, 18:382-390.